(0.27%) 5 145.50 points
(0.29%) 38 551 points
(0.38%) 17 914 points
(-0.75%) $83.22
(1.66%) $1.955
(-0.24%) $2 341.60
(1.04%) $27.54
(0.60%) $927.60
(-0.25%) $0.932
(-0.22%) $11.00
(-0.34%) $0.798
(0.86%) $92.66
@ $6.23
Utstedt: 14 feb 2024 @ 21:20
Avkastning: -54.41%
Forrige signal: feb 14 - 16:48
Forrige signal:
Avkastning: -7.02 %
Live Chart Being Loaded With Signals
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine...
Stats | |
---|---|
Dagens volum | 136 838 |
Gjennomsnittsvolum | 280 352 |
Markedsverdi | 15.66M |
EPS | $0 ( 2024-02-15 ) |
Neste inntjeningsdato | ( $-2.20 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.150 |
ATR14 | $0.0140 (0.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-12 | Cr Group L.p. | Buy | 1 647 315 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 390 142 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 682 036 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 424 716 | Common Stock |
2024-04-12 | Cr Group L.p. | Buy | 136 409 | Common Stock |
INSIDER POWER |
---|
3.77 |
Last 99 transactions |
Buy: 52 592 861 | Sell: 43 240 632 |
Volum Korrelasjon
T2 Biosystems Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
COLB | 0.924 |
CBAN | 0.923 |
CARA | 0.92 |
CBLI | 0.914 |
ARQT | 0.9 |
CSSE | 0.893 |
CSF | 0.891 |
FMBH | 0.889 |
FRST | 0.889 |
DNLI | 0.887 |
10 Mest negative korrelasjoner | |
---|---|
OFLX | -0.906 |
BLPH | -0.906 |
BCYP | -0.867 |
MNDY | -0.863 |
BNIXU | -0.857 |
SVFC | -0.857 |
INTA | -0.856 |
ASLN | -0.854 |
MKGI | -0.851 |
AZRX | -0.85 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
T2 Biosystems Inc Korrelasjon - Valuta/Råvare
T2 Biosystems Inc Økonomi
Annual | 2023 |
Omsetning: | $7.19M |
Bruttogevinst: | $-8.83M (-122.74 %) |
EPS: | $-19.19 |
FY | 2023 |
Omsetning: | $7.19M |
Bruttogevinst: | $-8.83M (-122.74 %) |
EPS: | $-19.19 |
FY | 2022 |
Omsetning: | $22.31M |
Bruttogevinst: | $1.17M (5.23 %) |
EPS: | $-1 242.48 |
FY | 2021 |
Omsetning: | $28.06M |
Bruttogevinst: | $7.36M (26.21 %) |
EPS: | $-20.29 |
Financial Reports:
No articles found.
T2 Biosystems Inc
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance to identify carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company has collaboration agreements with Canon U.S. Life Sciences, Inc. to develop a diagnostic test panel to detect Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.